GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.0200 $0.0500 Thursday, 18th Apr 2024 CALA stock ended at $0.0251. This is 37.38% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 0% from a day low at $0.0251 to a day high of $0.0251.
90 days $0.0200 $0.120
52 weeks $0.0100 $0.500

Historical Calithera Biosciences prices

Date Open High Low Close Volume
2021-05-28 $2.28 $2.39 $2.27 $2.28 549 736
2021-05-27 $2.16 $2.33 $2.14 $2.25 1 879 144
2021-05-26 $2.12 $2.20 $2.09 $2.16 815 787
2021-05-25 $2.14 $2.15 $2.09 $2.10 430 555
2021-05-24 $2.13 $2.16 $2.07 $2.14 1 119 437
2021-05-21 $2.16 $2.18 $2.10 $2.11 749 244
2021-05-20 $2.14 $2.20 $2.10 $2.13 543 034
2021-05-19 $2.17 $2.18 $2.07 $2.15 1 197 955
2021-05-18 $2.14 $2.25 $2.12 $2.18 1 910 870
2021-05-17 $2.29 $2.33 $2.10 $2.16 5 663 437
2021-05-14 $1.98 $2.09 $1.95 $2.03 467 823
2021-05-13 $2.02 $2.06 $1.96 $1.98 690 204
2021-05-12 $1.99 $2.23 $1.98 $2.01 1 063 718
2021-05-11 $1.88 $2.00 $1.87 $1.98 620 743
2021-05-10 $2.10 $2.10 $1.93 $1.96 985 201
2021-05-07 $2.10 $2.15 $2.04 $2.09 810 785
2021-05-06 $2.12 $2.12 $2.03 $2.08 677 601
2021-05-05 $2.07 $2.13 $2.05 $2.10 632 169
2021-05-04 $2.19 $2.19 $2.06 $2.06 600 617
2021-05-03 $2.18 $2.23 $2.14 $2.19 602 816
2021-04-30 $2.16 $2.21 $2.12 $2.17 585 311
2021-04-29 $2.37 $2.37 $2.18 $2.20 671 184
2021-04-28 $2.25 $2.39 $2.22 $2.32 894 096
2021-04-27 $2.34 $2.35 $2.22 $2.25 448 704
2021-04-26 $2.21 $2.34 $2.17 $2.32 878 746
Click to get the best stock tips daily for free!

About Calithera Biosciences

Calithera Biosciences Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company offers INCB001158, an orally bioavailable arginase inhibitor of arginase that is in Phase 1/2 clinical trial for the treatment of hematology and oncology. It is developing CB-280, an oral arginas... CALA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT